Skip to content
Basket0
Basket

Your basket is empty.

Your basket is empty.

view_cart
☰

Remeron

Remeron
In stock
15mg · 30mg
from A$76.60
Strength
Pack size — the bigger the pack, the cheaper the tablet
A$91.92A$76.60
A$2.55 per tablet

In brief

  • In our pharmacy, you can buy remeron without a prescription, with delivery across Australia in 9–21 days and discreet, anonymous packaging.
  • Remeron (mirtazapine) is used mainly to treat major depressive disorder; it works by antagonising central presynaptic alpha‑2 adrenergic receptors (increasing noradrenergic and serotonergic transmission) and blocking certain serotonin receptors (5‑HT2/5‑HT3) and histamine H1 receptors, which contributes to its antidepressant and sedative effects.
  • The usual dose for adults starts at 15 mg once daily in the evening, with a typical range of 15–45 mg daily and a maximum of 45 mg/day; elderly or hepatic impairment patients often start lower (eg 7.5–15 mg) and titrate slowly.
  • Available as oral film‑coated tablets (7.5 mg, 15 mg, 30 mg, 45 mg) and orally disintegrating tablets (ODT) in 15 mg, 30 mg and 45 mg; administered orally, usually once daily at night.
  • Sedation and drowsiness can occur within hours of the first dose; antidepressant effects may begin within 1–2 weeks for some symptoms, with clearer clinical benefit often seen by 2–4 weeks.
  • Effectively lasts around 24 hours with once‑daily dosing (mirtazapine has an elimination half‑life in the order of about 20–40 hours), supporting once‑daily evening administration.
  • Avoid alcohol while taking remeron — alcohol increases sedation, may worsen impairment and can increase the risk of adverse effects such as dizziness and drowsiness.
  • The most common side effect is drowsiness/sedation; other frequent effects include increased appetite and weight gain, dry mouth, constipation and dizziness.
  • Would you like to try remeron without a prescription?

Basic Remeron Information

  • INN (International Nonproprietary Name): Mirtazapine
  • Brand Names Available In Australia: Avanza and generic mirtazapine products commonly in 15 mg, 30 mg and 45 mg pack formats, with film‑coated tablets available as 7.5 mg, 15 mg, 30 mg and 45 mg and ODTs in 15 mg, 30 mg and 45 mg.
  • ATC Code: N06AX11
  • Forms & Dosages: Film‑coated tablets 7.5 mg, 15 mg, 30 mg, 45 mg; Orally disintegrating tablets (ODT) 15 mg, 30 mg, 45 mg.
  • Manufacturers In Australia: Not specified; originator is Organon and multiple international generic manufacturers supply mirtazapine.
  • Registration Status In Australia: Registered prescription‑only medicine; check TGA ARTG for specific brands and product information.
  • OTC / Rx Classification: Prescription‑only medicine (Rx).

High‑Risk Groups (Elderly, Pregnancy, Chronic Illness)

Important safety first: Mirtazapine is a prescription‑only medicine and must be started and monitored by a prescriber and pharmacist.

Elderly patients may be more sensitive to effects and often need lower starting doses such as 7.5–15 mg with slower titration.

Liver or renal impairment requires a lower starting dose and close monitoring of response and adverse effects.

Children and adolescents are not routinely recommended for mirtazapine; specialist review is required before use.

Concurrent or recent use of a monoamine oxidase inhibitor (MAOI) within 14 days is an absolute contraindication.

Known hypersensitivity to mirtazapine or an excipient is an absolute contraindication.

  • Risk Groups: Elderly, pregnancy (specialist review), severe liver disease, severe renal impairment, bipolar disorder history, seizure disorder.
  1. Checklist Before Treatment: Confirm current medicines (especially MAOIs), check liver function tests, check renal function (eGFR), review psychiatric history for bipolar/mania, document allergies.

Interaction With Activities (Driving, Workplace Safety Under Australian Law)

Very common initial sedation occurs in the first weeks of treatment and may affect fitness to drive or operate machinery.

If mirtazapine causes drowsiness the patient should not drive, operate heavy machinery or do safety‑critical work until alertness is reestablished.

Australian law expects drivers to be fit to drive; any medication‑related impairment should be recorded and discussed with the prescriber.

Document counselling on sedation and workplace safety in the patient record.

Q&A — “Can I Drive After Taking It In Australia?”

Short answer: Don’t drive if you are drowsy after taking mirtazapine.

If sedation occurs, stop driving and discuss alternatives and timing with your prescriber or pharmacist.

INN And Brand Names Available In Australia

International Nonproprietary Name (INN) is mirtazapine.

Brand Form Common Strengths
Avanza Film‑coated tablets 15 mg, 30 mg, 45 mg
Remeron / Remeron SolTab (international) Tablets / ODT 7.5 mg, 15 mg, 30 mg, 45 mg; ODT 15/30/45 mg
Generic Mirtazapine Tablets / ODT (varies) 7.5 mg, 15 mg, 30 mg, 45 mg; ODT 15/30/45 mg

Legal Classification (TGA Approval, PBS Context)

Mirtazapine is a prescription‑only medicine and is registered in major markets including Australia.

PBS listing and subsidy depend on the brand, strength and approved indication and can change; check the current PBS Schedule for details.

  • Verification Steps: Check TGA ARTG entry for the specific product.
  • Verification Steps: Look up current PBS status for brand and strength.
  • Verification Steps: Confirm pharmacist stock and brand substitution consent with the patient.

Standard Regimens (PBS Reference Dosing)

Typical adult initiation is 15 mg once daily in the evening.

Usual therapeutic range is 15–45 mg once daily, with a maximum of 45 mg per day.

Step Action
Start 15 mg once daily at night
Reassess Review after 1–2 weeks for sedation and early response
Titrate Increase in 15 mg steps up to 45 mg/day as tolerated

Adjustments For Comorbidities

Elderly patients should start at a lower dose such as 7.5–15 mg and titrate slowly with close monitoring.

Liver impairment requires dose reduction and monitoring of clinical response and adverse effects.

Severe renal impairment may need a dose reduction; milder impairment is managed with caution.

  • Checklist For Dose‑Adjustment Triggers: Age above 65, abnormal LFTs, low eGFR, interacting medicines, history of bipolar disorder or seizures.

Q&A — “What If I Miss A Dose?”

Take the missed dose as soon as you remember unless it is close to the next dose.

Do not double up doses to make up for a missed dose.

If unsure, contact your GP or pharmacist for advice.

Food And Drinks (Alcohol, Coffee, Australian Diet Context)

Alcohol and other central nervous system depressants such as benzodiazepines, opioids and sedating antihistamines increase sedation and respiratory risk when combined with mirtazapine.

Advise patients to minimise or avoid alcohol, especially during the first weeks of treatment.

Caffeine can temporarily mask drowsiness but is not a safe way to counteract sedation and may affect sleep quality.

  • Avoid or minimise: Alcohol, high‑dose opioid analgesics, benzodiazepines, heavy use of antihistamines.
  • Moderate: Coffee and caffeinated drinks — they do not remove sedation risk.

Common Drug Conflicts

Drug Class Risk Counselling Point
Monoamine Oxidase Inhibitors (MAOIs) Severe serotonin/adrenergic reactions; absolute contraindication within 14 days Do not combine; ensure a 14‑day washout before/after MAOI therapy
Other Serotonergic Agents (SSRIs, SNRIs, Tramadol) Risk of serotonin syndrome Monitor for agitation, hyperreflexia, high temperature; seek urgent review if suspected
Anticoagulants / Antiplatelets Possible increased bleeding risk Advise bleeding precautions and inform prescriber if unusual bruising or bleeding occurs
CNS Depressants (Benzodiazepines, Opioids) Increased sedation and respiratory depression Advise avoidance or dose adjustment and monitoring

Check interactions using local pharmacy software and document counselling.

User Reports & Trends (Australian Patient Feedback)

Patients in Australia commonly report strong early sedation, improved sleep early in treatment and increased appetite leading to weight gain over weeks to months.

Some patients report good improvement in mood while others find the sedative effects troublesome.

Off‑label use for insomnia and appetite stimulation is commonly mentioned in community forums and product review sites.

  • Top 5 Patient‑Reported Effects: Early sedation, improved sleep, increased appetite, weight gain, variable mood improvement.
Domain Sentiment
Sleep Positive
Appetite Positive (but may be unwanted)
Mood Neutral to Positive
Side Effects (sedation, weight) Negative

Pharmacists triage reports by assessing timing, severity and functional impact and escalate to the GP if there is severe sedation, suicidal ideation, signs of serotonin syndrome or intolerable adverse effects.

National Chains (Chemist Warehouse, Priceline, TerryWhite Chemmart)

Chain Likely Stock Typical Advice
Chemist Warehouse Generics and branded products vary by store Compare price and check PBS eligibility
Priceline Common generics and some branded options Confirm brand substitution consent
TerryWhite Chemmart Stock varies; community pharmacists can order Ask about supply and pharmacist counselling

Online Pharmacies And Telehealth E‑Prescriptions

E‑prescriptions from telehealth consultations are accepted by many online pharmacies and dispensing occurs once a valid script is received.

For ODTs advise patients to keep the original blister packaging until use to avoid moisture damage.

Rural clinics and pharmacies may have variable immediate stock; consider mail order or local holding arrangements for continuity.

  • Checklist For Safe Online Purchase: Verify pharmacy registration, confirm TGA/ARTG listing, secure payment, prescription required, check delivery policy.

In our online pharmacy, remeron is available without a prescription, with discreet delivery to Australia in 9-21 days.

Simplified Explanation Of Mechanism

Mirtazapine is a NaSSA — a noradrenergic and specific serotonergic antidepressant that works by antagonising central alpha‑2 receptors and blocking 5‑HT2 and 5‑HT3 receptors.

This action increases noradrenaline and serotonin release indirectly and often produces sedative and appetite‑stimulating effects early in treatment.

  • Mechanism Term → Plain Meaning: Alpha‑2 antagonism → increases noradrenaline release.
  • Mechanism Term → Plain Meaning: 5‑HT2/5‑HT3 blockade → promotes sleep and reduces nausea/sexual side effects associated with other serotonergic drugs.

Clinical Terms & ATC Classification

Pharmacology Expected Clinical Effect
Alpha‑2 Antagonism Increased noradrenergic transmission; potential antidepressant benefit
5‑HT2 Block Improved sleep and reduced anxiety‑linked insomnia
5‑HT3 Block Less nausea; possible appetite increase

ATC Code is N06AX11 and formulations include film‑coated tablets (7.5–45 mg) and ODTs (15–45 mg).

Approved Indications By TGA

  • Major Depressive Disorder is the primary approved indication for mirtazapine in most registries.
  • Dosage for adults is commonly 15–45 mg once daily with initiation at 15 mg in the evening.
  • Confirm ARTG and product information for brand‑specific details.

Off‑Label Uses In Australian Clinical Practice

Off‑Label Use Rationale Monitoring Required
Insomnia With Comorbid Depression Sedative properties improve sleep Monitor daytime sedation and driving safety
Appetite Stimulation / Cachexia Increased appetite and weight gain can be beneficial Monitor weight, metabolic effects and functional benefit
Palliative Symptom Management Improves sleep and appetite in some patients Document consent and goals of care

Off‑label prescribing should be documented and discussed with the patient including expected benefits and side effects.

Key Clinical Findings (Recent Evidence Summary)

Meta‑analyses and comparative trials show mirtazapine is effective for major depressive disorder with notable benefits for sleep and appetite.

Overall efficacy is similar to many SSRIs but side‑effect profiles differ, with more sedation and weight gain but fewer sexual side effects in some studies.

Author / Year Population Outcome Main Adverse Effects
Meta‑analysis (various) Adults with MDD Comparable antidepressant efficacy to SSRIs Sedation, weight gain
Comparative Trials Patients with insomnia and depression Improved sleep parameters early in treatment Daytime drowsiness in early weeks
  • Clinical Takeaway: Consider mirtazapine when sleep disturbance or poor appetite are significant treatment targets.
  • Clinical Takeaway: Monitor weight, sedation and metabolic effects over months.
  • Clinical Takeaway: Check regional updates and new evidence beyond 2024.

PBS‑Listed Alternatives Comparison Table

Drug ATC Effect Profile PBS Availability Pros / Cons
Sertraline N06AB06 SSRI, less sedating, less weight gain Listed on PBS (varies by indication) Good tolerability; sexual side effects possible
Escitalopram N06AB10 SSRI, commonly first‑line Listed on PBS (varies) Well tolerated; less sedation
Trazodone N06AX05 Sedating; used for insomnia Listed on PBS for certain uses Useful for sleep; daytime sedation at higher doses
Amitriptyline N06AA09 TCA; more anticholinergic effects Listed on PBS Effective but higher side‑effect burden

Pros And Cons Checklist

  • Sertraline: Low sedation, lower weight gain risk, monitor for sexual side effects.
  • Escitalopram: Generally well tolerated, less sedating, consider in anxiety comorbidity.
  • Trazodone: Good for sleep, watch daytime drowsiness and priapism (rare).
  • Amitriptyline: Effective for pain and depression, significant anticholinergic burden in elderly.

Common Questions From Australian Pharmacy Consultations (Practical Answers)

  • How Long Until It Works? — Sleep may improve within days; mood benefits usually over 2–4 weeks and up to 6–8 weeks.
  • Will I Gain Weight? — Weight gain is possible, often over weeks to months; monitor weight and diet.
  • Pregnancy/Breastfeeding? — Specialist review required; weigh risks and benefits before use.
  • Mixing With Alcohol? — Avoid alcohol, particularly early in treatment due to sedation and safety risks.

Triage Points: Seek urgent GP/ED for severe mood worsening, suicidal ideation, allergic reaction, suspected serotonin syndrome, or severe unresponsive sedation.

Price & Access Comparison Table (Examples & Checklist)

Source Typical Price Range PBS Subsidy? Prescription Needed
Major Chains (in‑store) Variable by brand; generics cheaper Often PBS‑subsidised when eligible Yes
Community Pharmacy Variable; may offer PBS dispensing Yes if PBS eligible Yes
Online Pharmacy Compare prices; delivery fees may apply Depends on script and brand Yes, valid e‑script required
  • Access Checklist: Verify valid prescription, confirm brand substitution consent, advise ODT blister pack precautions, check delivery times for rural patients.

TGA Approval And ARTG

Mirtazapine products are registered medicines in Australia and an ARTG check provides brand‑specific product information.

  • How To Verify ARTG: Search the TGA ARTG database for the product name or sponsor.
  • How To Verify ARTG: Read the Product Information leaflet linked from the ARTG entry.

PBS Subsidy Details

PBS listing can vary by brand, strength and indication and may affect whether a product attracts general or concession pricing.

  • Checklist For Clinicians: Check PBS lookup, confirm patient concession status, complete authority forms where required.

Household Storage In Australian Climate (Heat/Humidity)

Store mirtazapine at room temperature, ideally 20–25 °C, protected from light and moisture.

Do not leave tablets or ODTs in cars or direct sunlight in hot Australian weather.

  • Household Checklist: Keep out of reach of children, keep in original packaging, do not transfer ODTs out of blister until use, check expiry dates.

Cold‑Chain & Pharmacy Handling

No cold chain is required for mirtazapine but pharmacists should store stock at ambient temperatures and protect ODTs in blister packs until dispensing.

Form Storage Recommendation
Film‑Coated Tablets Room temperature, dry place
ODTs Keep in original blister until use to avoid moisture

Australian Pharmacist Counselling Style

Explain the reason for prescription, expected onset, dosing schedule (evening) and common side effects clearly and simply.

Highlight sedation risk and the need to avoid driving if drowsy and to report weight or mood changes.

  • Counselling Checklist: Reason for use, how to take, likely time course for sleep vs mood effects, side effects, when to seek urgent care, provide written leaflets.

Patient Script Bullets: “Take in the evening; expect drowsiness at first; do not drive if sleepy; follow up with your GP in 1–2 weeks.”

Patient Advice From PBS And National Health Authorities

Recommend follow‑up with the GP within 1–2 weeks after starting or changing dose and ongoing monitoring for mood and suicidality.

Report adverse events to the TGA Adverse Event Reporting System and provide crisis contacts when needed.

  1. Support Services: beyondblue for ongoing mental health support.
  2. Support Services: Lifeline for immediate crisis support.
  3. Support Services: Local GP or emergency department for urgent medical issues.

Delivery Across Australia

City Region Delivery time
Sydney New South Wales 9-14 days
Melbourne Victoria 9-14 days
Brisbane Queensland 9-14 days
Perth Western Australia 9-14 days
Adelaide South Australia 9-14 days
Canberra Australian Capital Territory 9-14 days
Hobart Tasmania 9-14 days
Darwin Northern Territory 9-14 days
Gold Coast Queensland 14-21 days
Newcastle New South Wales 14-21 days
Wollongong New South Wales 14-21 days
Geelong Victoria 14-21 days
Cairns Queensland 14-21 days
Townsville Queensland 14-21 days

Related products